Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model.
about
Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancerCancer Risk and Eicosanoid Production: Interaction between the Protective Effect of Long Chain Omega-3 Polyunsaturated Fatty Acid Intake and GenotypeRole of n-3 Polyunsaturated Fatty Acids and Exercise in Breast Cancer Prevention: Identifying Common Targetsn-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer.The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancerα-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways.
P2860
Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mammary tumour development is ...... l)-YD5 transgenic mouse model.
@ast
Mammary tumour development is ...... l)-YD5 transgenic mouse model.
@en
type
label
Mammary tumour development is ...... l)-YD5 transgenic mouse model.
@ast
Mammary tumour development is ...... l)-YD5 transgenic mouse model.
@en
prefLabel
Mammary tumour development is ...... l)-YD5 transgenic mouse model.
@ast
Mammary tumour development is ...... l)-YD5 transgenic mouse model.
@en
P2093
P2860
P356
P1476
Mammary tumour development is ...... l)-YD5 transgenic mouse model.
@en
P2093
Kate Perez
Michael A Leslie
Salma A Abdelmagid
William J Muller
P2860
P2888
P356
10.1186/1476-511X-13-96
P577
2014-06-11T00:00:00Z
P6179
1039366473